RA Capital Management and Synthego News

This is selected news for RA Capital Management and Synthego, which are filed under Capital Firms and Sectors / Healthtech, respectively. There are 10 news items for this page.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
2/18/2022 Synthego Raises $200 Million to Accelerate the Field of CRISPR-Based Medicines from Early-Phase Research to the Clinic
... round were new investors SoftBank Vision Fund 2, Declaration Partners, Laurion Capital Management, Logos Capital, GigaFund and Chimera Abu Dhabi and existing investors Wellington Management, RA Capital Management and Moore Strategic Ventures. The company also recently appointed Avi Raval as chief financial officer. ‚AuCRISPR has become a powerful discovery tool ...
thejournalofprecisionmedicine.com
2/18/2022 Synthego raises $200m to accelerate discoveries of new therapeutics
post] [this site] Led by Perceptive Advisors, the financing round has seen participation from existing investors RA Capital Management, Wellington Management, and Moore Strategic Ventures. The new investors include Declaration Partners, The post Synthego raises $200m to accelerate discoveries of new therapeutics appeared first on Pharmaceutical Business review ...
pharmaleaders.com
2/17/2022 Synthego Raises $200 Million to Accelerate the Field of CRISPR-Based Medicines from Early-phase Research to the Clinic
... round were new investors SoftBank Vision Fund 2, Declaration Partners, Laurion Capital Management, Logos Capital, GigaFund and Chimera Abu Dhabi and existing investors Wellington Management, RA Capital Management and Moore Strategic Ventures. The company also recently appointed Avi Raval as chief financial officer. "CRISPR has become a powerful discovery tool ...
PR Newswire
2/17/2022 Gene Editing Tech Firm Synthego Raises $200M From VC Investors | Genomeweb
NEW YORK Gene editing firm Synthego on Thursday said it has raised $200 million from a group of new and existing investors. The funding includes a Series E financing round led by Perceptive Advisors, with new investors SoftBank Vision Fund 2, Declaration Partners, Laurion Capital Management, Logos Capital, GigaFund ...
genomeweb.com
2/17/2022 Synthego Raises $200 Million to Accelerate the Field of CRISPR-Based Medicines
... participation by new investors SoftBank Vision Fund 2, Declaration Partners, Laurion Capital Management, Logos Capital, GigaFund and Chimera Abu Dhabi, and existing investors Wellington Management, RA Capital Management and Moore Strategic Ventures. ‚AuCRISPR has become a powerful discovery tool, and the field is now at an inflection point. The promise ...
globalgenes.org
8/28/2020 Synthego Raises $100 Million to Accelerate CRISPR Platform Scale-Up in Response to Growing Demand
Synthego, the genome engineering company, announced that it raised $100 million in a Series D financing led by new investor Wellington Management, co-led by RA Capital Management and 8VC. Additional investors that participated included Founders Fund, Menlo Ventures, and Intel Capital. This new round brings Synthego's total private funding ...
aithority.com
8/27/2020 Synthego Pulls In $100M Series D Financing
To export Synthego The round was led by new investor Wellington Management, co-led by RA Capital Management and 8VC. Additional investors that participated included Founders Fund, Menlo Ventures, and Intel Capital. This new round brings Synthego's total private funding to more than $250 million. The company also recently appointed ...
vcnewsdaily.com
8/27/2020 Synthego Raises $100M in Series D Funding
By FinSMEs Synthego , a Redwood City, Calif.-based genome engineering company, raised $100m in Series D financing. The round was led by new investor Wellington Management, co-led by RA Capital Management and 8VC. Additional investors included Founders Fund, Menlo Ventures, and Intel Capital. This new round brings Synthego's total ...
finsmes.com
8/27/2020 Synthego Raises $100 Million to Accelerate CRISPR Platform Scale-up in Response to Growing Demand
... the genome engineering company, today announced that it raised $100 million in a Series D financing led by new investor Wellington Management, co-led by RA Capital Management and 8VC. Additional investors that participated included Founders Fund, Menlo Ventures, and Intel Capital. This new round brings Synthego's total private funding ...
vcaonline.com
8/26/2020 Synthego Raises $100 Million to Accelerate CRISPR Platform Scale-up in Response to Growing Demand
REDWOOD CITY, Calif. Synthego, the genome engineering company, today announced that it raised $100 million in a Series D financing led by new investor Wellington Management, co-led by RA Capital Management and 8VC. Additional investors that participated included Founders Fund, Menlo Ventures, and Intel Capital. This new round brings ...
PR Newswire